These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9649096)

  • 1. Fetal heart rate and nuchal translucency in detecting chromosomal abnormalities other than Down syndrome.
    Martinez JM; Echevarría M; Borrell A; Puerto B; Ojuel J; Fortuny A
    Obstet Gynecol; 1998 Jul; 92(1):68-71. PubMed ID: 9649096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining nuchal translucency with umbilical Doppler velocimetry for detecting fetal trisomies in the first trimester of pregnancy.
    Martinez JM; Borrell A; Antolin E; Puerto B; Casals E; Ojuel J; Fortuny A
    Br J Obstet Gynaecol; 1997 Jan; 104(1):11-4. PubMed ID: 8988688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
    Hyett JA; Noble PL; Snijders RJ; Montenegro N; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Apr; 7(4):239-44. PubMed ID: 8726874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal heart rate patterns in pregnancies with chromosomal disorders or subsequent fetal loss.
    Martinez JM; Comas C; Ojuel J; Borrell A; Puerto B; Fortuny A
    Obstet Gynecol; 1996 Jan; 87(1):118-21. PubMed ID: 8532245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
    Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
    BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
    Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
    Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?
    Comas C; Torrents M; Muñoz A; Antolín E; Figueras F; Echevarría M
    Obstet Gynecol; 2002 Oct; 100(4):648-54. PubMed ID: 12383528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
    Nicolaides KH; Brizot ML; Snijders RJ
    Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
    Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH
    Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study].
    Jemmali M; Valat AS; Poulain P; Favre R; Bourgeot P; Subtil D; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):538-43. PubMed ID: 10598347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
    Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
    Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
    Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.